For millions of people, eating is far more than simply satisfying hunger. Some people experience repeated episodes where they eat very large amounts of food in a short period and feel completely unable to stop, even when they want to.
This condition is known as binge eating disorder. It can affect people of any body size and often causes deep emotional distress. Many people blame themselves for their eating, even though binge eating disorder is a recognized medical condition that usually requires professional treatment.
Because there are currently no medicines specifically approved for the disorder, researchers continue searching for better ways to help patients.
Scientists from University College London have now examined whether a popular class of weight-loss medicines might also reduce binge eating symptoms. Their findings were published in the medical journal eClinicalMedicine.
The medicines studied belong to a group called GLP-1 receptor agonists. They include semaglutide, liraglutide, and tirzepatide. These drugs copy the action of a natural hormone that helps regulate appetite.
They make people feel fuller after meals, slow the movement of food through the stomach, improve blood sugar control, and may also influence brain pathways involved in food cravings and reward.
Rather than performing a single experiment, the researchers gathered and analyzed results from 25 randomized controlled trials involving 8,069 people across 12 countries. Combining many studies in this way allows scientists to look for overall patterns that individual studies may be too small to detect.
The combined results suggested that people taking GLP-1 medicines had fewer binge eating episodes than those who did not receive the medicines.
They also experienced less emotional eating and fewer situations where they felt they had completely lost control over eating. These improvements suggest the medicines may affect both physical hunger and the emotional processes linked to overeating.
One interesting finding was that participants reported stronger control over their food choices. However, the researchers cautioned that this result should not automatically be viewed as positive.
Healthy eating control is different from unhealthy food restriction, and future research will need to determine whether these medicines could unintentionally encourage harmful eating patterns in some people.
The research team also consulted people who have personally experienced binge eating disorder. They emphasized that recovery usually involves much more than medication. Psychological treatment, family and community support, reducing weight stigma, and improving access to healthcare remain essential parts of successful long-term care.
The study has several limitations that should be considered. Many of the included trials were supported by drug manufacturers, and many were not specifically designed to study people formally diagnosed with binge eating disorder.
Because of this, scientists cannot yet be completely confident that the benefits seen in the review will apply to every patient with the condition.
The researchers believe these findings should encourage governments and research organizations to fund larger independent clinical trials with longer follow-up periods. Such studies would help determine whether the benefits continue over time and whether the medicines are safe and effective for routine treatment.
This review represents an important step forward because it suggests that medicines originally developed for obesity and diabetes may also improve symptoms of binge eating disorder. At the same time, the evidence remains preliminary. The study offers hope but not final answers.
Future research will determine whether GLP-1 medicines become part of standard treatment alongside counseling, psychological therapy, nutritional support, and social care. For now, the findings are promising and deserve further investigation, but they should be interpreted with appropriate caution until stronger evidence becomes available.
If you care about weight loss, please read studies that hop extract could reduce belly fat in overweight people, and early time-restricted eating could help lose weight .
For more health information, please see recent studies about a simple path to weight loss, and results showing a non-invasive treatment for obesity and diabetes.
Source: University College London.
